TriangleDupilumab (NCT06088771)
Dupilumab trial for Non-Small Cell Lung Cancer (NCT06088771). This is a short film with English narration. The transcript is on this page, and the written brief is separate.
Lo que dice el vídeo
Lee la transcripción
This trial is for early stage non small cell lung cancer that can be removed by surgery, in adults.
The idea: give immunotherapy before surgery. On day 1, patients receive dupilumab, which targets IL 4 receptor alpha, by two injections under the skin, and cemiplimab, an anti PD 1 antibody, by vein. Standard surgery is scheduled around day 15. Patients are then followed for side effects.
This phase 1 and 2 trial plans 21 patients. At the Icahn School of Medicine at Mount Sinai in New York, Thomas Marron leads it.
Public record; not medical advice.
¿Ya estás en un ensayo?
Se convierte en un proyecto que hay que manejar: citas, estudios de imagen, análisis, efectos secundarios y papeleo. Triangle lo mantiene organizado en un solo lugar, para ti o para quien te ayuda.
Organizar mi ensayoPrueba gratuita de 7 días, después $9 al mes. Cancela cuando quieras.
Cómo funcionan estos ensayos: qué es de verdad la fase 1 · preguntas frecuentes No es evidencia clínica.